Stem cells in gastric cancer.

Area of Science:

• Gastroenterology
• Oncology
• Stem Cell Biology

Background:

• Gastric cancer (GC) is a major global health concern, with cancer stem cells (CSCs) implicated in its initiation, spread, and relapse.
• Normal gastric stem cells (GSCs) are crucial for stomach tissue renewal and repair, with specific populations identified in different stomach regions.
• CSCs are thought to originate from transformed GSCs or de-differentiated progenitor cells.

Purpose of the Study:

• To review the current understanding of normal gastric stem cells (GSCs) and gastric cancer stem cells (CSCs).
• To highlight the role of GSCs and CSCs in the development and progression of gastric cancer.
• To discuss the therapeutic potential of targeting CSCs for gastric cancer treatment.

Main Methods:

• Review of existing literature on GSCs and CSCs in gastric cancer.
• Analysis of studies identifying specific GSC populations (Villin+, Lgr5+, Troy+, Sox2+).
• Examination of research on the role of cell surface markers (CD133, CD44) in defining gastric CSCs.

Main Results:

• Specific GSC populations (Villin+, Lgr5+, Troy+, Sox2+) regulate normal gastric function.
• Disruption of tumor suppressors in GSCs can lead to gastric cancer in mouse models.
• Gastric CSCs, identified by CD133 or CD44, are present in both mouse models and human GC tissues.
• Targeting CSCs has shown efficacy in reducing tumor size and grade in preclinical models.

Conclusions:

• The identification of normal GSCs and gastric CSCs has significantly advanced the understanding of gastric cancer's molecular and cellular basis.
• Gastric CSCs are critical drivers of gastric cancer, making them promising therapeutic targets.
• Further research into GSCs and CSCs is essential for developing more effective gastric cancer therapies.